Guest blog by Robbie Turner, Director of England, Royal Pharmaceutical Society
With people living longer lives, the number living with multiple long-term conditions is rising, leading to billions of pounds in additional health and social care costs. This will be a scenario very familiar to the members of ARMA.
Treatment and support for the growing number of people with long term conditions such as arthritis and other musculoskeletal conditions is placing significant demands on the NHS and other public services. Around £15 billion was spent on medicines in 2015/16, which are the most common solution chosen to help manage symptoms for people with long term conditions. …
Read more of this article